Abstract Digital PCR is poised to make a significant impact on disease research and the development of molecular diagnostics. Its ability to precisely analyze nucleic acids at a molecular level makes it ideal for tasks such as detecting copy number variation and point mutations. In th
Breaking the Sensitivity Barrier, Digital PCR Technology Offers Absolute Quantification Pierre Laurent-Puig and collaborators use a new dPCR platform to track circulating tumor DNA, finding rare mutations that were previously undetectable. When Pierre Laurent-Puig evaluates a new tech
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.